Prazosin May Lower Prostate Cancer Recurrence Risk After Radiotherapy
LUTS treatment with the alpha-blocker prazosin was associated with significantly lower 2- and 5-year biochemical recurrence rates vs tamsulosin and non-use of alpha-blockers.
Lower Urinary Tract Symptoms
Male Bladder Bacteria, LUTS Severity Linked
Lower urinary tract symptom severity in men is associated with detectable bacteria in urine obtained via catheter, new study suggests.
Aquablation Safe, Effective in LUTS Sufferers With Large Prostates
Significant improvements in symptoms, peak flow rate, and post-void residual volume observed in men with prostate volumes of 80 to 150 cc.
New LUTS Classification for Women Proposed
Women presenting with lower urinary tract symptoms cluster into 4 distinct symptom groups, according to a recent study.
Nocturnal Polyuria Linked to Non-Dipping Blood Pressure
More than three-quarters of men with nocturnal polyuria had non-dipping blood pressure compared with less than half of men with other causes of nocturia.
AUA Issues New Surgical Treatment Guidelines for LUTS
New clinical guidelines for the surgical management of lower urinary tract symptoms attributable to enlarged prostate offer 22 recommendations.
Inactivity, Sitting Tied to LUTS in Men
Low physical activity may increase risk of lower urinary tract symptoms in study of Korean men
Sexual Adverse Effects of BPH Drug Treatment Clarified
Decrease in scores on the Men’s Sexual Health Questionnaire mostly due to ejaculation disorders.
Water Ablation for BPH Lessens Risk of Ejaculatory Dysfunction
A novel approach called “Aquablation” provides results comparable to TURP, but with a decreased likelihood of retrograde ejaculation.
Prostatic Urethral Lift Benefits Durable Out to 5 Years
Patients who underwent the minimally invasive procedure had a 36%, 50%, and 44% improvement in IPSS, quality of life, and peak flow rate, respectively, at 5 years.
Next post in Benign Prostatic Hyperplasia (BPH)
